Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

Stocks To Watch Today, March 19. LIC to Buy Stake in Health Insurer . Life insurance behemoth LIC is confident of buying a ...

The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 mg. Shares of Zydus Lifesciences Ltd ended at ₹901.15, up by ₹7.85, or 0.88% ...

Bajaj Auto, BPCL, GR Infra, Paytm, LIC, Zydus Lifesciences are among the top stocks to watch today, March 19, 2025 ...

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline ...

Zydus Lifesciences Ltd has received USFDA approval to manufacture a generic version of Apalutamide tablets for prostate cancer treatment. The 60 mg tablets will be produced in Ahmedabad, addressing a ...

Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.